BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30999771)

  • 1. Non-conventional compounds with potential therapeutic effects against Alzheimer's disease.
    de Castro AA; Soares FV; Pereira AF; Polisel DA; Caetano MS; Leal DHS; da Cunha EFF; Nepovimova E; Kuca K; Ramalho TC
    Expert Rev Neurother; 2019 May; 19(5):375-395. PubMed ID: 30999771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylene blue and Alzheimer's disease.
    Oz M; Lorke DE; Petroianu GA
    Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese medicines and Alzheimer's disease.
    Wu TY; Chen CP; Jinn TR
    Taiwan J Obstet Gynecol; 2011 Jun; 50(2):131-5. PubMed ID: 21791295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
    Dey A; Bhattacharya R; Mukherjee A; Pandey DK
    Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Ayurvedic and herbal remedies for Alzheimer's disease: from bench to bedside.
    Sharma R; Kuca K; Nepovimova E; Kabra A; Rao MM; Prajapati PK
    Expert Rev Neurother; 2019 May; 19(5):359-374. PubMed ID: 30884983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging amyloid and tau targeting treatments for Alzheimer's disease.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):697-711. PubMed ID: 28490214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?
    Ovsepian SV; O'Leary VB
    Neurotherapeutics; 2018 Oct; 15(4):1032-1035. PubMed ID: 30242774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effects of Herbal Chemicals in Traditional Chinese Medicine on Alzheimer's Disease.
    Cheung TS; Song TH; Ng TB; Wu FH; Lao LX; Tang SC; Ho JC; Zhang KY; Sze SC
    Curr Med Chem; 2015; 22(19):2392-403. PubMed ID: 25989911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
    Moussa CE
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1131-1136. PubMed ID: 28817311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE inhibitors as potential therapeutics for Alzheimer's disease.
    Evin G; Kenche VB
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):188-99. PubMed ID: 18221231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
    Tayeb HO; Yang HD; Price BH; Tarazi FI
    Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.